I think you're confusing yourself here. Your own link quoted 'exports from the UK' and didn't specify where, although as I recall this had more to do with movements between Ireland/NI. There are also problems reported with production in the Dutch plant, but that doesn't mean that all other issues are null and superseded.
AIUI, there were problems with both the Dutch and Belgium plants getting started, and either or both may still be performing less well than hoped for, but I think both are now producing. [1] [2] [3]
I assume you're talking about what VDL said, which isn't something that would specifically affect Ireland/NI (that was the invocation of article 16, which isn't going to happen):
She has said that, in contrast, the EU is still waiting for vaccine exports from the UK and she warned last week that if supplies in Europe do not improve, the bloc "will reflect whether exports to countries who have higher vaccination rates than us are still proportionate".
There would appear to be a significant difference between what VDL claims and what's actually been happening, which is that doses that would have come to the UK from the NL plant over the past month or so have not been shipped. One might well speculate that this is because of the risk of the shipments being blocked.
The exports to the UK seem to have been all of Pfizer [2], who are (along with Moderna) also "delivering their contracts" (
0:38) to the EU.
So I don't think I am confused that the rhetoric about "exports from the UK" and "reciprocity" is merely a way to put a veneer of acceptability on taking the doses from NL by force. I know that sounds a bit hot-takey and strong, but certainly the EU would've known since at least the discussions with AstraZeneca in January that the NL doses were destined for the UK.
I mean, fair enough, I can see why they would justifiably be angry about that. Especially since the UK's vaccination programme has gone along very well without doses from there. But that has not been what they've been saying!
- - - -
Another point, that
I've posted about before, is scale. Two weeks ago,
VDL said that 300 million doses would be delivered in the EU in the second quarter. (Given the timing, I assume that figure is despite the AstraZeneca shortfall of 70 million). This makes any amount that might be exported from the UK miniscule by comparison. The entire output of the plant in NL is much more relevant.
- - - - -
[1]
Reuters reports that UK has had a request for a shipment from NL refused by the EU, so there's something there worth having.
[2] From
BBC live feed:
14:57
UK 'does not receive any AstraZeneca vaccines from EU'
Rachel Schraer
BBC Health Reporter
During a briefing, executive vice president at AstraZeneca, Ruud Dobber, said the UK did not receive any of its AstraZeneca vaccines or components from the EU.
Fellow executive vice president Mene Pangalos then clarified that one "tiny" batch which "hasn't been approved yet" had been sent to the UK from Halix, a plant in the Netherlands that has an agreement with AstraZeneca to manufacture the vaccine.
Imported batches of vaccine have to be tested on arrival.
Halix was one of the University of Oxford's original partners for manufacturing the vaccine, Reuters reported.
The UK is mostly self-sufficient when it comes to the Oxford-AstraZeneca vaccine - and has ordered 100 million doses of the jab.
The EU is mainly being supplied with the AZ vaccine by the US and by a site in Belgium, the company confirmed.
[3] "The diplomats insist it's not in anyone's interest to have vaccines or vaccine components "sitting in a warehouse" when the aim - on both sides of the Channel - is to get needles into arms". -
BBC.